Sunday, July 27, 2025 11:52:10 AM
This observation is 🔐 IMHO
It was not designed to produce millions of identical vials. It was designed to receive cryopreserved therapies, match them with patient-specific boosters, serialize and label per batch, and dispatch under GMP. That matches DCVax, not any known product in Merckās public pipeline.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities ⢠InvestorsHub NewsWire ⢠05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities ⢠GlobeNewswire Inc. ⢠05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform ⢠PR Newswire (US) ⢠04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform ⢠PR Newswire (US) ⢠04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic ⢠PR Newswire (US) ⢠04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic ⢠PR Newswire (US) ⢠04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness ⢠Edgar (US Regulatory) ⢠04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement ⢠Edgar (US Regulatory) ⢠04/16/2026 09:25:30 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 ⢠Edgar (US Regulatory) ⢠03/31/2026 09:04:37 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠01/15/2026 10:06:20 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements ⢠Edgar (US Regulatory) ⢠11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] ⢠Edgar (US Regulatory) ⢠11/25/2025 10:23:07 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements ⢠Edgar (US Regulatory) ⢠11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] ⢠Edgar (US Regulatory) ⢠11/14/2025 09:44:21 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠10/31/2025 04:29:10 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠10/30/2025 08:40:05 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠10/24/2025 04:28:38 PM
- Form 8-K - Current report ⢠Edgar (US Regulatory) ⢠10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] ⢠Edgar (US Regulatory) ⢠08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] ⢠Edgar (US Regulatory) ⢠07/01/2025 09:04:38 PM
